Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19
Completed · Not applicable
Conditions studied: Covid19
In brief
The purpose of this study is to learn how to better detect infection and understand how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes lung disease and is spread. The novel device called PneumoniaCheck is a safe way to collect material from the lung from coughs. Study participants will collect cough specimens over a 24 hour period.
Key facts
- Study ID
- NCT04912895
- Run by
- Emory University
- People needed
- 69
- Starts
- 2021-04-14
- Expected to finish
- 2022-08-05
- Last updated by the study team
- 2023-09-07
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Being treated for an acute respiratory illness either as inpatients or outpatients at Emory University Hospital
- English is a primary spoken language
You may not qualify if…
- none
- Inclusion Criteria for Healthy Volunteers:
- Prior registration in an adult participant database and agreed to be contacted for future studies
- English is a primary spoken language
Where it is running
- Emory University Hospital Midtown — Atlanta, Georgia, United States
- Emory Children's Center — Atlanta, Georgia, United States
- Emory University Hospital — Atlanta, Georgia, United States
- Wesley Woods Center — Atlanta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.